Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|9|1518-1522

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.9, 2015-09, pp. : 1518-1522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hispanic ethnicity as a risk factor for requiring glucarpidase rescue in pediatric patients receiving high‐dose methotrexate

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : E40-E42

John Wiley & Sons Inc

Access to resources Recommend Favorite

Secondary pseudotumor cerebri in pediatric oncology and hematology: An unpredictable condition of varying etiology

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 49, Iss. 7, 2007-12 ,pp. : 1029-1033

John Wiley & Sons Inc

Access to resources Recommend Favorite

AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia

By  

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2482-2489

John Wiley & Sons Inc

Access to resources Recommend Favorite

Depressive symptoms and SSRI use in pediatric oncology patients

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 49, Iss. 7, 2007-12 ,pp. : 881-887

John Wiley & Sons Inc

Access to resources Recommend Favorite

Participation in pediatric oncology: views of child and adolescent patients

By  

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 25, Iss. 9, 2016-09 ,pp. : 1036-1042

John Wiley & Sons Inc

Access to resources Recommend Favorite